Poly Medicure
BSE:531768 Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
WA
Consensus Narrative from 6 Analysts
FDA Approvals, New Plants, And Product Expansion Into Renal And Cardiology To Drive Revenue Growth And Boost Margins
Key Takeaways Expansion of production capacity and investments in high-growth areas like cardiology and dialysis could drive significant revenue and market share growth. Strategic entry into the U.S. market and increased automation promise improved margins and robust earnings growth.
View narrative₹2.52k
FV
11.8% undervalued intrinsic discount22.22%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
23 days ago author updated this narrative